The Patent Finder
US

Antibodies for Treatment of Cancer Expressing Claudin 6

US 11,859,008 In force
OverviewFamilyAssignmentsSources & methods

Term ends Apr 20, 2032 · Low confidence

Filed Dec 30, 2020 as application 17/138,403 · Granted Jan 2, 2024
Base term plus 423 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
20 years from filing
2012 2032
Clock starts
Apr 20, 2012
Term ends
Apr 20, 2032
Granted
Jan 2, 2024
base term Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
423
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 10,233,253, US 10,919,974, US 9,321,842.
0 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
6
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term runs 423 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 0 of 2 maintenance fees are paid so far. Confidence: Low. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Apr 20, 2012, when application PCT/EP2012/001721, the earliest non-provisional in its chain, was filed (this one was filed Dec 30, 2020); a parent in its chain could not be resolved (the next row)Apr 20, 2032High confidence
Continuity chainA parent in the chain could not be resolveddated from this application's own claimMedium confidence
Patent term adjustment+423 days, USPTO patent term adjustment recordJun 17, 2033High confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 10,233,253, US 10,919,974, US 9,321,842)capped to Apr 20, 2032High confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events0 of 2 maintenance fees paidIn forceHigh confidence
Further caveats on recordThe record names parents not resolved: 16028210, 14117118, 14117118Low confidence overallLow confidence
Computed term endThe steps above, in orderApr 20, 2032Low confidence

This family

US 9,321,842In force
Aug 2032
Aug 2032
US 10,233,253In force
Apr 2032
Apr 2032
US 10,919,974In force
Apr 2032
Apr 2032
US 11,859,008this patent
Apr 2032
Apr 2032
Application 18/520,264Pending
not computed
not computed
5 of 6 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jul 18, 2023
Reel 64309, frame 964
Sahin, Ugur; Türeci, Ölzem; Koslowski, Michael; Walter, Korden; Wöll, Stefan; Hubner, Bernd; Erdeljan, Michael; Weichel, Michael; Kreuzberg, MariaGanymed Pharmaceuticals AG; Johannes Gutenberg-Universität MainzAssignment of Assignor's Interest
Jul 18, 2023
Reel 64318, frame 431
Ganymed Pharmaceuticals AGGanymed Pharmaceuticals GmbHChange of Name
Jul 18, 2023
reel/frame not recorded
Sahin, Ugur; Hubner, Bernd; Koslowski, Michael; Weichel, Michael; Erdeljan, Michael; Kreuzberg, Maria; Türeci, Ölzem; Walter, Korden; Wöll, StefanGanymed Pharmaceuticals AGAssignment of Assignor's Interest
Jul 18, 2023
reel/frame not recorded
Sahin, Ugur; Hubner, Bernd; Koslowski, Michael; Weichel, Michael; Erdeljan, Michael; Kreuzberg, Maria; Türeci, Ölzem; Walter, Korden; Wöll, StefanJohannes Gutenberg-Universität MainzAssignment of Assignor's Interest
Jan 19, 2024
Reel 66183, frame 749
Ganymed Pharmaceuticals GmbHAstellas Pharma Inc.Assignment of Assignor's Interest
Jan 19, 2024
Reel 66183, frame 773
Johannes Gutenberg-Universitat MainzTron - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz Gemeinnützige GmbHAssignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited